Cronos vs Niagen Bioscience: revenue, profit, margins and growth compared
Cronos brought in $193.4M of revenue in fiscal 2025, Niagen Bioscience $129.4M in fiscal 2025. Revenue changed by +19.5% at Cronos and +29.9% at Niagen Bioscience on the year before, so Niagen Bioscience grew faster. Cronos kept -4.9% of its revenue as net profit, Niagen Bioscience 13.4%.
Fiscal years as each company reports them; the two may end in different months.
Questions about Cronos and Niagen Bioscience
Which is bigger by revenue, Cronos or Niagen Bioscience?
Cronos is bigger by revenue: $193.4M in fiscal 2025, against $129.4M for Niagen Bioscience in fiscal 2025.
Which keeps more of its revenue as profit, Cronos or Niagen Bioscience?
Cronos had a net margin of -4.9% in fiscal 2025; Niagen Bioscience had 13.4% in fiscal 2025.
Which grew revenue faster, Cronos or Niagen Bioscience?
In their latest fiscal years revenue changed by +19.5% at Cronos and +29.9% at Niagen Bioscience.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.